DJIA 16,514.37 65.12 0.40%
NASDAQ 4,161.46 0.00 0.00%
S&P 500 1,879.55 7.66 0.41%
market minute promo

5.70 0.36 (6.74%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

OREX $5.70 6.74%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.38
Previous Close $5.34
Daily Range $5.38 - $5.79
52-Week Range $4.60 - $7.84
Market Cap $635.8M
P/E Ratio -6.68
Dividend (Yield) $0.00 (0.0%)
Volume 2,156,549
Average Daily Volume 2,479,075
Current FY EPS -$0.07





Orexigen Therapeutics, Inc. (OREX) Description

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity. Website:

News & Commentary Rss Feed

What Arena's Belviq Television Ad Campaign Means For The Stock

Is Orexigen Attractive Near 52-Week Lows?

Relative Strength Alert For Orexigen Therapeutics

OREX Makes Notable Cross Below Critical Moving Average

Narrower Loss at Orexigen in Q4 - Analyst Blog

Have Anti-Obesity Drug Companies Failed?

Arena Earnings On Tap

Orexigen Sees Positives In European Application For Contrave

Arena Pharmaceuticals, Inc. Earnings: What to Expect Thursday

Will the obesity-drug maker avoid its biggest competitor's fate?

Why SINA, VIVUS, and Tenet Healthcare Tumbled Today

Even as the stock market gave up a small amount of ground today, these stocks got hammered hard. Find out why here.

See More OREX News...

OREX's Top Competitors

OREX $5.70 (6.74%)
Current stock: OREX
AMGN $119.30 (1.95%)
Current stock: AMGN
GILD $72.86 (1.76%)
Current stock: GILD
BIIB $306.20 (2.76%)
Current stock: BIIB